Acute Myeloid Leukemia (AML) remains one of the most challenging hematological malignancies to treat, with relapse and refractory cases continuing to pose significant hurdles ...

As the dengue virus continues to be a significant global health concern, an international research team led by Duke-NUS ...

One patient showed a transient 21% decrease in PSA associated with the increase in NK cell activity and function ... company focused on developing treatments that target the innate immune system to ...

Immunotherapeutic approaches have substantially improved the treatment of patients with advanced malignancies. However, most ...

Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing immune cell therapies for the treatment of ...

Visos teisės saugomos. © 2024 UAB „Lrytas“. Kopijuoti, dauginti, platinti galima tik gavus raštišką UAB „Lrytas“ sutikimą.

So-called high-dose flu vaccines are available for older people. The reason: their immune system does not always respond ...

Nonpathogenic E. coli displaying decoy-resistant IL18 demonstrate potent anti-tumor responses and boost CAR-NK cell ...

The risk of COVID might have lessened, but long COVID remains a worry for many people. Researchers are looking for risk ...

Autumn is a time of change - not only for nature, but also for our bodies. Cooler temperatures and the transition from summer ...

Maxim Group analyst Jason McCarthy has maintained their bullish stance on INMB stock, giving a Buy rating yesterday. Jason McCarthy has given ...